Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2)

Abstract

The Global Parkinson’s Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Towns C, Richer M, Jasaityte S, et al. Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2). NPJ Parkinsons Dis. 2023;9(1):131. Published 2023 Sep 12. doi:10.1038/s41531-023-00533-w
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
NPJ Parkinson's Disease
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}